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4D magnetic resonance imaging applications towards MR-guided
proton therapy of pancreatic cancer
Abdominal organ motion compromises the targeting accuracy of proton therapy of pan-
creatic cancer. Time-resolved volumetric magnetic resonance imaging (4D-MRI) is a
promising technology to visualize organ motion and deformation while providing a high
soft-tissue contrast and avoiding additional imaging doses. The aim of this thesis is to
quantify motion-induced impacts on dosimetry, based on 4D-MRI, and to determine suit-
able strategies to improve the treatments.
For this purpose, a method was developed that utilizes repeated 4D-MRI measurements
to analyze motion-induced impacts on dosimetry along the treatment course in proton
therapy. The clinical impact of organ motion was evaluated in a patient cohort by sta-
tistical analyses. Moreover, counter-strategies to mitigate the motion-induced dosimetric
impacts were investigated using abdominal corsets or beam-gating.
Fractionation helps to reduce the motion-induced tumor underdosage substantially. How-
ever, especially for patients with large motion amplitudes, further motion mitigation may
be required. Physical compression by abdominal corsets and beam-gating with certain
pre-selected gating criteria showed high potential to improve the dose distributions.
The developed method allows an eﬀective evaluation of the motion-induced dosimetric un-
certainties and is applicable in both pre-treatment and prospective real-time MR-guided
proton therapy scenarios with online MR imaging during irradiation.
This cumulative dissertation comprises six peer-reviewed publications.

Anwendungen von 4D-Magnetresonanztomographie auf dem Weg
zur MR-geführten Protonentherapie von Bauchspeicheldrüsenkrebs
Abdominelle Organbewegung beeinträchtigt die Bestrahlungsgenauigkeit in der Proto-
nentherapie von Patienten mit Bauchspeicheldrüsenkrebs. Zeitaufgelöste volumetrische
Magnetresonanztomographie (4D-MRT) ist eine neuartige Bildgebungsmodalität, die
es ermöglicht, Organbewegungen und Deformationen mit hohem Weichgewebekontrast
darzustellen, ohne die Patienten zusätzlicher ionisierender Strahlung auszusetzen. Ziel
dieser Dissertation ist es, mittels 4D-MRT den Einﬂuss von Organbewegung während
der Bestrahlung auf die resultierende Dosisverteilung zu quantiﬁzieren und geeignete
Möglichkeiten zur Bewegungsreduktions zu ermitteln.
Dazu wurde eine Methode entwickelt, die es ermöglicht, basierend auf 4D-MRT Messun-
gen, die dosimetrische Auswirkung von Organbewegung während der Protonentherapie zu
quantiﬁzieren. Anhand von Patientendaten wurden derartige Auswirkungen auf klinisch
relevante Größen statistisch analysiert. Zudem wurden verschiedene Möglichkeiten zur
eﬀektiven Bewegungsreduktion mittels abdomineller Korsetts oder Gating-Strategien, in
denen nur während bestimmter Atmungsphasen bestrahlt wird, untersucht.
Während für einige Patienten der resultierenden Unterdosierung im Tumor mittels
Fraktionierung entgegengewirkt werden konnte, zeigte sich, dass vor allem für Patien-
ten mit großen Organbewegungsamplituden weitere Bewegungskompensationsmaßnah-
men notwendig sind. Abdominelle Korsetts zur physischen Bewegungsreduktion, aber
auch Gating-Strategien stellten sich dabei als vielversprechende Ansätze heraus um die
Dosisverteilungen zu optimieren.
Die entwickelte Methode ermöglicht eine eﬀektive Analyse der bewegungsinduzierten
dosimetrischen Unsicherheiten und kann auch in zukünftiger MR-geführter Protonen-
therapie mit Echtzeit MRT-Bildgebung angewendet werden.
Dieser kumulativen Dissertation liegen sechs Publikationen zu Grunde, die von Experten
begutachtet und in Fachzeitschriften veröﬀentlicht wurden.
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1. Introduction
If you can't see it, you can't hit it.
And if you can't hit it, you can't cure it! [1]
Harold Johns (1915-1988), Canda
Medical Physicist
1.1 Radiation Therapy
Radiation therapy utilizes ionizing radiation to cause damage to cancerous cells. This is
mainly achieved by means of induced double-strand breaks in the DNA along the tracks
of ionizing radiation, which may ﬁnally lead to cell deaths or prevent further tumor
growth [2].
The discovery of X-rays by Wilhelm Conrad Röntgen in 1895 [3] set the basis for the
development of radiation therapy. Since then, huge scientiﬁc progress gradually improved
the delivery and treatment techniques to allow more precise and eﬀective patient treat-
ments with improved survival rates [4]. Nowadays, in most of the cases, external photon
irradiation is used to deliver a prescribed amount of dose (energy per mass) to the tu-
mor while at the same time trying to spare healthy tissues in the beam path. In photon
therapy, these combined goals are usually achieved by irradiation from multiple angles
and shaped irradiation ﬁelds with modulated intensities of the photon beams, so-called
intensity-modulated radiation therapy (IMRT) [5]. It allows a highly localized dose in the
tumor while keeping the undesired dose to organs at risk (OAR) at a low toxicity level.
The depth-dose proﬁle of X-rays shows its maximum a few centimeters after the X-rays
enter the patient's body. By means of electromagnetic interactions, the X-rays get expo-
nentially attenuated. Consequently, the delivered dose decreases with increasing depth.
This can lead to considerable dose depositions in the OARs, located in front of and be-
hind the tumor, see Figure 1.1, which may induce to undesired side eﬀects to the patients.
1
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ach, bowel, duodenum and the kidneys, particle therapy is considered a potentially more
eﬀective treatment than photon therapy by exploiting the Bragg-peak characteristics [14].
Being an abdominal organ, however, the pancreas is exposed to respiration-induced mo-
tion and pancreatic tumors are likely to move during every breathing cycle due to the
close vicinity to the diaphragm. Such abdominal organ motion counteracts the precision
of charged particle irradiation and may lead to signiﬁcant range uncertainties with the
risk of over- and undershooting of the target [15].
Moreover, particle irradiation beams are usually delivered using pencil-beam scanning
techniques, where the tumor is raster-scanned by a narrow particle beam that is moved
over the entire tumor volume [16]. Consequently, in presence of respiratory motion, a so-
called interplay eﬀect occurs between the motion of the scanning beam and the moving
tumor [17] which may lead to undesired pronounced dose heterogeneity and dosimetric
hot and cold spots in the target volume. Due to the highly localized dose deposition in the
Bragg peak, abdominal organ motion has a more severe impact in particle therapy than
in X-ray therapy, as in the latter, the rather smooth depth-dose curves are less susceptible
to anatomical changes.
In order to fully exploit the potential of particle therapy and to achieve a homogeneous
conformal dose deposition in the tumor with suﬃcient tumor coverage, organ motion and
its resulting dosimetric impact need to be quantiﬁed and taken into account in the pro-
cess of treatment planning. For such purposes, both the tumor localization and its motion
patterns need to be known. This requires (time-resolved) medical imaging techniques and
consecutive image-guided radiation therapy (IGRT).
1.2 Imaging in Radiation Therapy
1.2.1 Overview
Diﬀerent medical imaging technologies exist that are used for diagnosis, tumor staging
and treatment planning purposes. They can be divided into anatomical modalities, such
as computed tomography (CT), magnetic resonance imaging (MRI) or ultrasonography
(US), which yield information on the patients' anatomy, and physiological imaging modal-
ities such as positron emission tomography (PET) or single photon emission computed
tomography (SPECT) that provide information on the functionality of certain mecha-
nisms in the human body.
Computed tomography (CT) utilizes X-ray radiation to visualize the attenuation proper-
ties of diﬀerent tissue materials and provides anatomical images from which the resulting
3
CT Hounsﬁeld Units (HU) can be directly converted into electron densities for radiation
treatment planning purposes. CT imaging has the advantage of being a fast and geometri-
cally accuracte imaging modality. However, it comes along with additional dose exposure
to the patients and suﬀers from low soft-tissue contrast, which is especially unfavourable
in the abdominal region.
In contrary, magnetic resonance imaging (MRI), which makes use of quantum mechanical
spin properties of mainly protons in external magnetic ﬁelds, does not involve any addi-
tional dose deposition by ionizing irradiation and additionally provides a high soft-tissue
contrast [18,19].
As this thesis focuses on MRI applications for radiation therapy purposes, a short intro-
duction to MRI is presented in the following.
1.2.2 Magnetic Resonance Imaging
If an object or patient is placed in an external static magnetic ﬁeld ~B0, the number of
proton spins oriented parallel or anti-parallel to ~B0 is unequal, with the diﬀerence being
determined by the Boltzmann statistics. This results in a macroscopic net magnetization
~M0, that is oriented parallel to ~B0, conventionally deﬁned as the z-direction. By means of
transmitted radiofrequency (RF) pulses with an appropriate frequency close to the Lar-
mor frequency ω0 = γ · B0, where γ denotes the gyromagnetic ratio, ~M0 can be ﬂipped
by a ﬂipping angle α due to spin resonance eﬀects. This leads to a reduced longitudinal
magnetization component Mz in z-direction, and an increased magnetization component
Mxy in the xy-plane.
The contrast in MR images is determined by the tissue-speciﬁc relaxation times T1, T2
and T2∗, which are deﬁned by the phenomenological Bloch equations [20] that describe
the time evolution of a net magnetization vector ~M0.
The longitudinal relaxation time T1 denotes the characteristic tissue-speciﬁc time con-
stant that describes the time Mz needs to recover to its full amplitude | ~M0| in thermal
equilibrium after an RF excitation. For Mz = 0 at the time t = 0, the time evolution of
Mz is given by
Mz(t) = | ~M0| · (1− e
−t/T1). (1.1)
MR imaging sequences, i.e. a speciﬁc series of RF pulses and gradients, in which the MR
parameters are selected such as that the diﬀerences in T1-values between diﬀerent tissues
determine the predominant image contrast, are called T1-weighted sequences.
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On the other hand, the tissue-speciﬁc characteristic transversal relaxation time constant
T2 describes the dephasing time of the transversal magnetization component Mxy in the
xy-plane. Such dephasing eﬀects occur due to spin-spin interactions at the atomic level.
Furthermore, T1 relaxation is another cause for T2 relaxation.
For Mxy = Mxy,0 at t = 0, this dephasing process is described by an exponential decay:
Mxy = Mxy,0 · e
−t/T2. (1.2)
MR sequences that highlight the tissue-speciﬁc diﬀerences in T2 are called T2-weighted
sequences.
A third important relaxation time, T2∗, additionally considers inhomogeneities of the
magnetic ﬁeld, which lead to a faster transversal spin dephasing in reality, than described
by T2, i.e. T2∗ ≤ T2.
Generally, in MRI, the signal intensities and contrasts between diﬀerent tissue properties
can be manipulated by adjusting MRI-speciﬁc sequence parameters such as the repetition
time TR, the echo time TE and the ﬂip angle α. The repetition time TR determines the
time between two consecutive radiofrequency pulses that are transmitted into the patient
to cause the magnetization ~M0 to be tilted away by the ﬂip angle α from the longitudinal
z-axis. In so-called gradient echo sequences, a gradient magnetic ﬁeld is overlayed to the
static magnetic ﬁeld after an RF excitation of the spins, which leads to a decaying sig-
nal by dephasing of the spins. By reversing the process using a rephasing gradient with
opposite polarity, an echo signal is evoked, which is then measured by the read-out coil.
This time between the radiofrequency pulse and the echo of the signal, that is received
by the read-out coil, is called the echo time TE.
For MR-based motion quantiﬁcation purposes, the repetition time TR is commonly chosen
in the time range of a few milliseconds to obtain a high time resolution. In combination
with novel 4D reconstruction techniques using dedicated sampling strategies of the fre-
quency space (k -space), in which MR images are acquired, time-resolved volumetric MR
images (4D-MRI) can be obtained that cover multiple breathing cycles of the patient.
In this thesis, a gradient echo sequence using radial k -space sampling with golden an-
gle spacing was utilized with a subsequent iterative 4D reconstruction of the raw data.
The reconstruction is based on a k -space-center self-gating signal that provides up to 20
reconstructed overlapping breathing phases [21].
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Apart from the MRI advantage of providing a high soft-tissue contrast with no imaging
dose, MR images hold the disadvantage, compared to CT scans, of not providing any
material density information, as the MR intensities are determined by the pulse sequence
and the MR parameter settings. For dose calculation purposes in treatment planning,
such material density information is, however, essential and needs to be incorporated in
MR-only planning approaches, where the entire planning is done on MR images. Diﬀerent
approaches have been developed to generate MR-based synthetic CTs [2224] to integrate
this relevant material density information into MR-based treatment planning.
The high MR image quality, combined with the prevention of additional imaging dose to
the patient, makes MRI a powerful imaging modality. Especially the development of cine
MR sequences, i.e. multiple rapidly acquired 2D MR images, and 4D-MRI reconstruction
algorithms that allow spatial motion extraction over multiple breathing cycles (while con-
ventional 4D-CT imaging illustrates only a single snapshot of a breathing cycle) outline
the high potential of MRI with respect to motion characterization and quantiﬁcation for
radiation therapy purposes [21,25,26]. Radiation therapy, that is "guided" by MR images,
is called MR-guided radiation therapy (MRgRT) or, with respect to proton irradiation,
MR-guided proton therapy (MRgPT).
In an ideal MR-guided radiotherapy scenario, real-time MR imaging could potentially be
performed during irradiation to include the online imaging feedback of the current tumor
position and anatomical changes in the beam path into the irradiation delivery. In pho-
ton radiation therapy, hybrid MR-LINAC devices that combine online cine MR imaging
with X-ray irradiation of a linear accelerator, have recently been developed and put into
clinical practice [2730]. However, such devices do not yet exist for high-precision particle
irradiation, but may be available in the future [31].
Therefore, pre-treatment imaging needs to be included in the treatment planning at the
moment to investigate the motion-induced impacts on dosimetry and to determine strate-
gies to reduce either tumor motion or mitigate its impact. Dedicated 4D dose evaluation
studies are essential to assess such information on motion-induced dosimetric impacts and
can help to determine suitable treatment strategies.
In this thesis, repeated time-resolved volumetric MRI data sets (4D-MRI) were utilized
to investigate and quantify pancreatic motion patterns and the resulting dosimetric im-
pact on proton therapy of pancreatic cancer. Based on high-contrast 4D-MRI and novel
methods to quantify such motion-induced dosimetric uncertainties along the treatment
course, diﬀerent motion mitigation strategies were analyzed to determine suitable treat-
ment approaches to improve particle therapy of pancreatic cancer.
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The methods are developed with respect to current pre-treatment MR imaging strate-
gies, but could also be applied in prospective MR-guided proton therapy scenarios with
real-time MR imaging.
7
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The 4D-MRI data in this thesis were acquired by means of a T1-weighted gradient echo
sequence. The tissue-speciﬁc signal intensity S of such an MR sequence is given by [32]
S ∝
1− e−TR/T1
1− cosα · e−TR/T1
· e−TE/T2
∗
· sinα (2.1)
with the tissue-speciﬁc relaxation times T1 and T2∗, and the MRI-speciﬁc adjustable pa-
rameters repetition time TR, echo time TE and ﬂip angle α, which were introduced in
section 1.2.2.
The contrast optimization was performed in two steps: ﬁrst, the optimum parameter set-
tings were determined in a simulation study, based on tissue-speciﬁc relaxation times of
the pancreas and surrounding organs (TR = 3.3 ms, TE = 1.5 ms, α = 10 − 12◦). Sec-
ond, a validation of the optimal parameter settings was performed by a volunteer study.
4D-MRI data sets were acquired for nine volunteers with diﬀerent parameter settings of
the gradient echo sequence. A delineation-based contrast analysis of the resulting 4D-MR
images conﬁrmed the resulting high contrast in the optimized setting determined in the
simulation study. These results were additionally conﬁrmed in a blind analysis by three
physicians, who rated the images of the volunteer study based on the visual contrast of
the pancreas to its adjacent organs.
2.2 4D-MRI-based Analysis of the Interplay Eﬀect
Based on high-contrast 4D-MR images, a patient study with nine pancreatic cancer
patients, who underwent particle therapy at the Heidelberg Ion-Beam Therapy Center
(HIT), was initiated. Up to six repeated 4D-MRI scans of the patients were acquired
along their respective treatment course to visualize and investigate tumor motion pat-
terns and to quantify the resulting dosimetric impact on fractionated proton therapy, in
which the entire treatment is divided into multiple irradiation sessions on diﬀerent days.
In collaboration with the Paul-Scherrer Institute (Villigen/Switzerland), a method was
developed to quantify the evolution of the motion-induced interplay eﬀect along the treat-
ment course for pencil-beam scanning proton therapy of pancreatic cancer (II). In this
workﬂow, static treatment planning CTs of these nine patients were deformed by means
of deformation vector ﬁelds (DVFs), extracted from multiple 4D-MRI data sets of the
patients, to generate multiple synthetic 4D-CTs. Static irradiation treatment plans were
calculated on the static CTs and the impact of motion was determined by a comprehensive
4D dose calculation study on the synthetic 4D-CTs. In this study, the multiple synthetic
10
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4D-CTs for each patient with variable tumor motion patterns were then utilized as sam-
ples for an estimation of the evolution of the interplay eﬀect along the entire treatment
course with 28 fractions.
A clinical-oriented study (III) revealed pronounced inter-patient variations of the inter-
play eﬀect with remarkable dose heterogeneity and low coverage of the tumor volume in
single treatment fractions. Signiﬁcant correlations between the interplay eﬀect and tumor
motion quantities were determined and clinically relevant pre-treatment imaging strate-
gies were investigated to estimate the interplay eﬀect.
The novel developed methods based on repeated 4D-MRI data sets allowed a statistical
analysis of the motion-induced dosimetric impacts as a function of the numbers of treat-
ment fractions. The studies revealed a pronounced statistical mitigation of the interplay
eﬀect by fractionation with suﬃcient tumor coverage after on average seven fractions
for the underlying patient cohort. However, for small numbers of treatment fractions
(hypofractionated treatments) or patients with large tumor motion amplitudes, the 4D
analyses showed that further motion mitigation would be required to reduce the dosimetric
impact of abdominal organ motion to meet clinical requirements.
2.3 Dosimetric Improvements by Motion Mitigation
Consecutive studies were performed with respect to motion reduction and mitigation tech-
niques such as beam-gating (IV) and the usage of abdominal corsets (I,V).
In beam-gating scenarios, the irradiation beam is only turned on while the tumor position
fulﬁlls certain pre-selected criteria and is turned oﬀ otherwise. Assuming online 4D-MR
imaging during prospective MR-guided proton treatments, a comprehensive gating study
was performed for a cohort of pancreatic cancer patients. The eﬀectiveness (assessed as
low residual interplay eﬀects) and eﬃciency (high duty cycles, i.e. low treatment times) of
various gating criteria were investigated, which were either based on absolute and relative
tumor motion amplitudes or on image-based tumor overlap criteria.
An eﬀective interplay mitigation with a highly homogeneous dose throughout the tumor
was observed for small gating windows, i.e. small residual motion amplitudes, which,
however, lead to pronounced longer treatment times. Relative gating criteria, based on
patient-speciﬁc 30% tumor motion amplitudes, showed to be most eﬀective while still
revealing a suﬃcient eﬃciency in single fractions. Inferior results were obtained for ﬁxed
gating thresholds or overlap criteria. Considering the entire treatment course, gating with
variable initial breathing phases resulted in a highly eﬀective combination of mitigation
of the interplay eﬀect by fractionation and intrinsically less hot- and cold-spots in each
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individual treatment fraction.
Since the interplay eﬀect was found to correlate with tumor motion amplitudes, physically
reduced abdominal motion oﬀers another possibility for a direct mitigation of the interplay
eﬀect. Such a physical motion restriction can be achieved by means of abdominal corsets.
A ﬁrst corset study (I) revealed a remarkable reduction of pancreatic motion and defor-
mation by means of abdominal corsets and showed an improved reproducibility of motion
patterns on diﬀerent days. In a second corset study (V), three diﬀerent types of abdomi-
nal corsets were compared to determine their suitability with respect to particle therapy
applications, taking into account the more stringent material requirements posed by parti-
cle therapy over conventional photon-based radiation therapy. Polyethylene-based corsets
were found to be suitable due to their homogeneous composition and constant thickness,
while polyurethane-based corsets, which have been already used in photon radiation ther-
apy, revealed to be non eligible in particle therapy.
2.4 Quality Assurance of MRI-based Motion
Extraction
All studies in this thesis utilized MRI-based extraction of abdominal organ motion. To
quantify the accuracy of the extracted motion parameters in cine-MRI and 4D-MRI, a
4D-MRI motion phantom was ﬁrst commissioned in collaboration with OncoRay (Dres-
den/Germany) and then utilized at an MR scanner with diﬀerent multi-dimensional mo-
tion patterns of the phantom target (VI). The motion uncertainties in fast cine-MRI and
4D-MRI were determined to be < 0.5 mm in the phantom measurements.
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3. Publications
This cumulative thesis comprises six peer-reviewed publications that have been published
in internationally recognized journals. The publications are numbered by roman numbers
from I-VI.
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Publication I
I 4DMRI-based analysis of inter- and inter-
fractional pancreas motion and deforma-
tion with different immobilization devices
Authors: Kai Dolde, Christian Dávid, Gernot Echner, Ralf Floca, Clemens Hentschke,
Florian Maier, Nina Niebuhr, Kai Ohmstedt, Nami Saito, Merkur Alimusaj, Beate Fluegel,
Patrick Naumann, Constantin Dreher, Martin Freitag, Asja Pfaﬀenberger.
Publications status (05/2019): Published.
Journal reference: Biomedical Physics and Engineering Express, 2019; 5, 025012
DOI: 10.1088/2057-1976/aaf9ae
Authors' contributions: KD organized and performed most of the 4D-MRI measure-
ments, and performed both the image processing and the data analysis. GE engineered
the setup board, NN supported in the MR measurements, CDá supported in the 4D-
MRI reconstructions. RF and CH provided support in image registration with the AVID
framework. PN, CDr and MF provided clinical input and evaluated the MR image data.
KO performed the delineations. MA and BF collaborated with respect to corset selection
and adjustments. AP, NS and FM supported the integration of the study into the overall
project strategy. KD drafted and revised the manuscript with critical review from AP,
PN, NS, FM, CH and RF.
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Publication II
II 4D dose calculation for pencil beam scan-
ning proton therapy of pancreatic cancer
using repeated 4DMRI datasets
Authors: Kai Dolde, Patrick Naumann, Christian Dávid, Regula Gnirs, Marc Kachel-
rieß, Antony Lomax, Nami Saito, Damien Weber, Asja Pfaﬀenberger, Ye Zhang.
 Both authors share last authorship.
Publications status (05/2019): Published.
Journal reference: Physics in Medicine and Biology, 2018; 63,165005
DOI: 10.1088/1361-6560/aad43f
Authors' contributions: KD developed the method to quantify the evolution of the
interplay eﬀect along the treatment course. PN recruited the patient for this pilot study.
KD and RG performed the MR measurements. CD and MK provided both software
and support for the 4D-MRI reconstructions, which were executed by KD. KD and YZ
generated the synthetic 4D-CTs and performed the 4D dose calculations. AP, DCW, AJL
and NS contributed with fruitful discussions, coordination and, as well as PN and YZ,
with critical revisions of the manuscript. AP and YZ supported the integration of the
study into the overall project strategy. KD performed the data analysis, drafted and
revised the manuscript.
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Publication III
III 4DMRI-based investigation on the interplay
effect for pencil beam scanning proton
therapy of pancreatic cancer patients
Authors: Kai Dolde*, Ye Zhang*, Naved Chaudhri, Christian Dávid, Marc Kachelrieß,
Antony Lomax, Damien Weber, Nami Saito, Asja Pfaﬀenberger.
* Both authors share ﬁrst authorship
Publications status (05/2019): Published.
Journal reference: Radiation Oncology, 2019; 14:30
DOI: 10.1186/s13014-019-1231-2
Authors' contributions: KD organized the MR measurements, was involved in the
data acquisition and processed the images. PN recruited the patients for this pilot study.
CD and MK provided both software and support for the 4D-MRI reconstructions. NC
provided important information on the treatment plans. KD and YZ generated the syn-
thetic 4D-CTs and performed the 4D dose calculations. KD performed the simulations of
fractionated treatments and the statistical data analysis. AP, DCW, AJL and NS con-
tributed with fruitful discussions, coordination and, as well as PN and YZ, with critical
revisions of the manuscript. AP and YZ supported the integration of the study into the
overall project strategy. KD drafted and revised the manuscript.
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Publication IV
IV Comparing the effectiveness and efficiency
of various gating approaches for PBS proton
therapy of pancreatic cancer using 4DMRI
datasets
Authors: Kai Dolde, Patrick Naumann, Christian Dávid, Marc Kachelrieß, Antony Lo-
max, Damien Weber, Nami Saito, Lucas Burigo, Asja Pfaﬀenberger, Ye Zhang.
Publications status (05/2019): Published.
Journal reference: Physics in Medicine and Biology, 2019; 64,085011
DOI: 10.1088/1361-6560/ab1175
Authors' contributions: KD conceived the idea of this comparison study and deﬁned
the diﬀerent gating strategies together with AP, NS and YZ. KD organized the MR mea-
surements, was involved in the data acquisition and processed the images. PN recruited
the patients for this pilot study. CD and MK provided both software and support for the
4D-MRI reconstructions. KD and YZ generated the synthetic 4D-CTs and performed the
4D dose calculations. KD performed the simulations and analysis of the diﬀerent gating
scenarios. AP, LB, DCW, AJL and NS contributed with fruitful discussions, coordina-
tion and, as well as PN and YZ, with critical revisions of the manuscript. AP and YZ
supported the integration of the study into the overall project strategy. KD drafted and
revised the manuscript.
59

Publication V
V Comparison of pancreatic respiratory mo-
tion management with three abdominal
corsets for particle radiation therapy
Authors: Kai Dolde*, Sergej Schneider*, Sarah Stefanowicz, Merkur Alimusaj, Beate
Fluegel, Nami Saito, Esther Troost, Asja Pfaﬀenberger, Aswin Hoﬀmann.
* Both authors share ﬁrst authorship
 Both authors share last authorship
Publications status (05/2019): In press.
Journal reference: Journal of Applied Clinical Medical Physics, 2019; xx:x,1-9
DOI: 10.1002/acm2.12613
Authors' contributions: KD and SSc conceived the idea of the corset comparison
study and performed the MRI measurements. MA and BF collaborated with respect to
corset adjustments. AP and AH supported the integration of the study into the overall
project strategy. KD performed the 4D-MRI measurements and the motion analysis,
SSc performed the WER analysis. KD and SSc drafted and revised the manuscript, KD
submitted the manuscript. AP, AH, NS, ET and SSt provided further ideas with respect
to the study and critically revised the manuscript.
73

Publication VI
VI Commissioning of a 4D MRI phantom for use
in MR-guided radiotherapy
Authors: Sergej Schneider*, Kai Dolde*, Johanna Engler, Aswin Hoﬀmann, Asja Pfaﬀenberger.
* Both authors share ﬁrst authorship
 Both authors share last authorship
Publications status (05/2019): Published.
Journal reference: Medical Physics, 2019; 46(1): 25-33
DOI: 10.1002/mp.13261
Authors' contributions: SS was devoted to the phantom setup, ﬁlling and operation.
KD and SS executed the phantom measurements together with AH and AP and performed
the motion analysis. JE and SS evaluated the distortion grid, SS further evaluated the
relaxation times. AP and AH supported the integration of the study into the overall
project strategy. SS and KD drafted and revised the manuscript with critical review by
AH and AP.
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4. Discussion
4.1 Beneﬁts and Limitations of 4D-MRI
4D-MRI is a promising and useful imaging modality to extract abdominal organ motion
and deformation. First, compared to conventional 4D-CT imaging, MRI oﬀers an in-
trinsic superior soft-tissue contrast and thus enables an improved diﬀerentiation between
abdominal organs. Dedicated MRI contrast optimizations by determination of suitable
MR-speciﬁc parameter sets (I) allow further improvements in the soft-tissue contrast and
set the basis for this 4D-MRI study on the impact of pancreatic motion in proton therapy.
Second, 4D-MRI does not expose patients to additional imaging dose by ionizing radiation
in contrary to 4D-CT imaging with radiation doses between 20-200 mGy [33]. This beneﬁt
can be exploited by acquiring repeated MRI data sets or longer imaging sessions that pro-
vide more comprehensive motion information than single snapshots of a speciﬁc breathing
cycle in a 4D-CT scan. Such repeated imaging is beneﬁcial to obtain information on day-
to-day motion variations and allows a more realistic estimation of motion-induced impacts
on dosimetry during an entire treatment course (II,III).
The 4D-MRI data in this thesis were obtained by utilizing a T1-weighted MR sequence
with radial stack-of-stars sampling at the golden angle, followed by a subsequent itera-
tive reconstruction algorithm that provide up to 20 overlapping breathing phases [21].
Such an iterative reconstruction procedure allows to utilize all raw image data, acquired
within diﬀerent breathing phases to reconstruct the image of a certain breathing phase.
In particular, the reconstruction alternates between image reconstruction and motion es-
timation. It iteratively reconstructs 3D images for each breathing phase, followed by the
estimation of deformation vector ﬁelds (DVFs) between diﬀerent breathing phases. The
entire image reconstruction procedure is based on deformable image registration (DIR)
and the Demons algorithm [34].
DIR is generally used to match a moving image to a ﬁxed image by determination of a
suitable DVFs between the two images. DIR itself, however, constitutes an intrinsically
ill-posed problem [35] and comes along with certain uncertainties. For instance, the ob-
tained DVFs and thus the extracted motion quantities strongly depend on the chosen
registration algorithm [36, 37]. Therefore, it is generally diﬃcult to determine precise
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motion quantities from patient measurements by DIR as generally no ground-truth infor-
mation of organ motion or deformation is available.
To quantify the accuracy of MR-extracted motion amplitudes, in this thesis a 4D-MRI
phantom was utilized (VI). First, the phantom was commissioned to determine the intrin-
sic accuracy between pre-set and actual motion patterns and then utilized on a clinical
MR scanner to assess the motion accuracy in cine-MRI and 4D-MRI data sets. While the
results showed a high motion accuracy with deviations < 0.5 mm, it needs to be noted
that these results were obtained for a purely rigid target motion. In patients, however,
organ deformations occur and low tissue contrasts or image artefacts can challenge mo-
tion extractions in a more severe way than it is the case in 4D motion phantoms. One
way to further investigate these additional uncertainties would be the usage of anthro-
pomorphic 4D phantoms, that allow to generate motion patterns within a patient-like
environment [38, 39]. Such phantoms have been used in previous studies to validate 4D-
MRI-based motion extraction, however, these phantoms usually reveal less reproducible
motion patterns than geometric, non-anthropomorphic phantoms due to more complex
setups [39].
For DIR evaluations of the real patient data, DIR quality assurance needs to be performed
by calculations of DIR-speciﬁc quantities such as Dice coeﬃcients, Jacobian determinants
and inverse consistency errors (ICE) [40]. They allow the determination of registration
uncertainties by, for instance, validation of contours (Dice) and DVFs (Jacobian, ICE)
and allow to keep the registration uncertainties at a tolerable level (I,II,III).
Alternatively to 4D-MRI, abdominal organ motion is often determined by cine-MRI, that
allows a fast real-time imaging modality in usually two dimensions [41]. Estimations of
3D motion patterns by cine-MRI can be achieved by stacking of 2D slices, acquired at
diﬀerent time points, by the acquisition of inter-leaved (orthogonal) 2D slices [42] or by
dedicated motion models that volumetrically interpolate 2D results based on oine 4D
models [43]. In contrary, 4D-MRI allows a voxelwise extraction of 3D DVFs to quantify
the spatial motion of each individual voxel. However, this additional useful information
comes along with a longer reconstruction time, compared to cine-MRI, which currently
limits the usability of 4D-MRI for real-time imaging. Nonetheless, novel approaches
based on deep learning algorithms [44,45] have already shown high potential in achieving
a short reconstruction time during the actual MR data acquisition opposite to a longer
pre-treatment learning phase. Such approaches may ﬁnally enable real-time 4D-MRI data
acquisition and reconstruction.
98
CHAPTER 4. DISCUSSION
4.2 Motion-induced Impact on Dosimetry
Abdominal organ motion leads to pronounced underdosage and heterogeneous dose dis-
tributions in pancreatic tumors due to the interplay eﬀect between the moving organ and
the scanning beam (II, III). In this thesis, a novel method was developed to quantify the
evolution of this interplay eﬀect along the treatment course by sampling the underlying
motion patterns, derived from DVFs of repeated 4D-MRI data sets.
The developed method, based on acquisitions of repeated 4D-MRI data sets, oﬀers the
beneﬁt of integrating both intra- and interfractional motion variations into the 4D dose
calculation. It further enables the utilization of pre-treatment 4D-MRI to estimate the
evolution of the interplay eﬀect along the treatment course and may provide support in
selection of suitable treatment strategies with respect to potentially necessary motion
mitigation.
The 4D dose calculation studies revealed a remarkable mitigation of the interplay eﬀect in
highly fractionated treatments due to redistribution of hot and cold spots along diﬀerent
treatment fractions. However, it should be noted that such a statistical wash-out may
not compensate the biological eﬀect of tumor underdosage in each single fraction. This
eﬀect should be investigated separately in a dedicated dose or eﬀect accumulation study.
Signiﬁcant correlations between tumor motion amplitudes and the interplay eﬀect were
observed and for patients with larger motion amplitudes, more fractions were required for
a suﬃcient mitigation of the interplay eﬀect. On average, after seven fractions a suﬃcient
tumor coverage was observed. This result may be aﬀected, however, by the rather small
tumor motion amplitudes in the underlying patient cohort with maximum amplitudes of
< 15 mm, while our volunteer study (I) as well as previous published studies reported
larger pancreatic motion of > 30 mm [41]. Such patients with large tumor motion am-
plitudes may require additional motion mitigation to exploit the full potential of proton
therapy.
4.3 Motion Mitigation Strategies
In this thesis, physical motion reduction by abdominal corsets (I,V) and residual motion
reduction by beam-gating (IV) were investigated. Abdominal corsets were observed to
remarkably reduce pancreatic motion and deformation in inferior-superior and anterior-
posterior direction. Consequently, the interplay eﬀect, which correlates to the motion
amplitudes, could be reduced by the use of abdominal corsets.
Additionally, abdominal corsets further enabled an increased reproducibility of motion
patterns within diﬀerent days with lower day-to-day motion variations. Lower organ mo-
tion and more reproducible motion patterns could be beneﬁcial for the integration of
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organ motion into 4D treatment planning process [46] and would be advantageous with
respect to tumor motion predictions in gating or tracking scenarios.
While diﬀerent kinds of corsets were found to reduce pancreatic motion, not all of them
were observed to be suitable for particle therapy, as particle therapy sets more stringent
material requirements in comparison to conventional photon-based radiation therapy. For
instance, density variations in the beam path are a considerable source of range uncertain-
ties in particle therapy [47]. While the applied polyethylene-based corsets showed a ho-
mogeneous thickness and material composition, foam-based polyurethane corsets showed
a highly variable thickness with multiple air inclusions within the foam (V). Therefore,
although foam-based corsets are already used in photon radiation therapy [48] and can
easily be patient-speciﬁcly adjusted, they were found to be unsuitable for particle ther-
apy purposes. In contrary, polyethylene-based corsets were found to be suitable and
could be easily included into the process of treatment planning due to their homogeneity
and known water-equivalent thickness. It should be noted that abdominal compression by
corsets may not be tolerable by certain patients because of abdominal pain. However, ﬁrst
preliminary results of a clinical trial at our partner facility OncoRay (Dresden/Germany)
indicated that such corsets are well-tolerated by pancreatic cancer patients (V).
Alternatively to active motion reduction by abdominal compression, a passive reduction
of the residual motion during irradiation by beam-gating was investigated. In this case,
irradiation only occurs while certain pre-selected gating criteria are fulﬁlled, e.g. within
certain breathing phases with low residual motion. In clinical practice, such gating trigger
signals are often derived from external surrogates such as pressure belts [49] or optical
surface monitoring devices [50] that detect the movement of the abdominal wall. How-
ever, possible correlations between external surrogate signals and tumor motion need to
be investigated with caution and may not be reliable [51,52].
For this reason, in this thesis 4D-MRI-based gating scenarios were investigated with re-
gard to possible prospective real-time MR imaging during proton irradiation. By allowing
a direct visualization of spatial tumor motion, it could be possible to avoid the dependency
on external surrogate signals or correlation models. In photon radiation therapy, image-
based gating approaches are already performed on hybrid MR-LINAC devices [2730].
However, these are currently based on single-slice cine-MR images which do not provide
spatial motion information.
In this thesis, 4D-MRI-based gating criteria, based on patient-speciﬁc relative 30% CTV
(clinical target volume) motion amplitudes, showed the signiﬁcantly lowest residual inter-
play eﬀect with still suﬃcient duty cycles, in contrast to inferior results by either ﬁxed
gating thresholds or CTV overlap criteria. Further improvements of the eﬀectiveness in
the mitigation of the interplay eﬀect along the treatment course were achieved by addi-
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tional variations of initial breathing phases in diﬀerent fractions.
If the start of beam delivery is not correlated with a speciﬁc breathing phase, the gating
advantages of lower interplay eﬀects in every single fraction were shown to come along
with a further eﬀective fractionation-induced mitigation of the interplay eﬀect (IV).
However, the performed gating analysis did not consider possible baseline shifts or ir-
regular breathing patterns. Both factors may prolong the duty cycles and may require
adaptations of the treatments. For such purposes, 4DDC simulations could give useful
guidance, to determine suitable adaptation strategies. Possible combinations of abdom-
inal corsets and beam-gating could potentially further combine the advantages of more
reproducible and reduced abdominal motion by corsets with further interplay mitigation
by beam-gating.
Alternatively to the investigated motion mitigation approaches in this study, fast rescan-
ning techniques have shown huge potential to smear-out hot and cold spots in the dose
distributions [53]. Apart from that, irradiation during breath-hold of the patients could
potentially eliminate the interplay eﬀect, but would require highly reproducible breath-
hold positions of the tumor. End-exhalation instead of end-inhalation breath-hold have
shown to be advantageous with this respect [54]. Alternatively, high dose rates would be
needed that enable a fast irradiation of an entire ﬁeld during a single breath-hold.
Future sophisticated options like real-time target tracking [55] for proton therapy of pan-
creatic cancer would require real-time volumetric imaging and precise information on
density variations in the beam path to handle range uncertainties which are currently
technically challenging.
4.4 MR-guided Proton Therapy
This thesis was dedicated to 4D-MRI applications towards prospective MR-guided pro-
ton therapy (MRgPT) with real-time MR imaging during proton irradiation. Due to its
longer history, image-guidance in photon therapy is far ahead of proton therapy. How-
ever, especially the advantages of MR-guidance are expected to yield higher beneﬁts to
proton therapy than the hybrid MR-LINAC devices oﬀer in photon therapy due to the
steep dose gradients in proton irradiation [31]. Online integration of MR imaging during
proton therapy is therefore expected to improve the treatments and reduce toxicity by
fully exploiting the clinical potential of high-precision proton irradiation [31].
First simulations on proton dosimetry in magnetic ﬁelds showed that in small magnetic
ﬁelds of 0.5 T, lateral beam deﬂections > 1 cm could occur. However, these deﬂections are
predictable and therefore could be accounted for in the treatment planning [56]. More-
over, it was reported that the dosimetric impact of magnetic ﬁelds in MR-guided proton
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therapy is rather small due to the low energy of the secondary electrons, generated by
protons [57]. Even for higher magnetic ﬁelds of 1.5 T, no dosimetric obstacles are ex-
pected [58]. Still, several major steps need to be taken to ﬁnally accomplish MR-guided
proton therapy, especially with respect to design, hardware and engineering of such a
device with its individual components and interactions between the MRI scanner and the
beam transport magnets [59]. Moreover, software developments for treatment planning
and target tracking in an MR-guided environment are essential in further developments.
In real-time MRgPT, 4D-MRI could potentially be acquired during the irradiation and
used for spatial target tracking for image-based gating or tracking applications. Further-
more, by means of the proposed method in this study of warping a static CT by DVFs
from 4D-MRI, the actual 4D dose distribution of the day could be calculated as a control
measure of the dose delivery after every fraction.
In current proton therapy with pre-treatment MR imaging, in a possible clinical work-
ﬂow, pre-treatment 4D-MRI data sets could be acquired and utilized for a subsequent 4D
interplay analysis along the estimated treatment course. Based on such an analysis and
pre-deﬁned criteria, patients who require dedicated motion reduction could potentially
be identiﬁed and treatment strategies, utilizing beam-gating, abdominal corsets or other
motion mitigation strategies, could be patient-speciﬁc adapted.
All in all, this thesis demonstrated the beneﬁts of 4D-MRI in proton therapy of pancreatic
cancer. 4D-MRI provides high soft-tissue contrast images without any imaging dose
and oﬀers various beneﬁcial applications in both prospective real-time and current pre-
treatment imaging scenarios. 4D-MRI constitutes a useful imaging tool as a basis to
analyze motion-induced dosimetric impacts and to determine suitable treatment strategies
for proton therapy of pancreatic cancer.
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Time-resolved volumetric magnetic resonance imaging (4D-MRI) enables spatial motion
extraction of respiration-induced abdominal organ motion while providing high soft-tissue
contrast and avoiding any imaging dose to patients.
Based on contrast-optimized data sets, this thesis utilized repeated 4D-MRI measurements
of pancreatic cancer patients and healthy volunteers to quantify pancreatic motion, in-
vestigate motion-induced impacts on dosimetry (interplay eﬀect) and determine suitable
treatment strategies for proton therapy of pancreatic cancer.
A novel 4D-MRI-based method was developed in this thesis to evaluate the evolution of
the interplay eﬀect along an entire treatment course. The results from 4D dose calcula-
tions showed pronounced tumor underdosage and heterogeneous dose distributions with
cold and hot spots in the tumor for single fractions. For patients with small tumor mo-
tion amplitudes (< 15 mm), these motion-induced eﬀect can be mitigated in fractionated
treatments due to the redistribution of the dosimetric hot and cold spots by day-to-day
variations of both motion patterns and initial breathing phases.
However, correlations between the interplay eﬀect and tumor motion amplitudes pointed
at the necessity of further motion mitigation for patients with larger motion amplitudes or
hypofractionated treatments. For such cases, homogeneously composed abdominal corsets
were identiﬁed to be suitable for particle therapy purposes. They remarkably reduce pan-
creatic motion and deformation, while at the same time, improve the reproducibility of
motion patterns on diﬀerent days which is beneﬁcial for motion prediction models in 4D
treatment planning.
Alternatively, beam-gating with pre-selected gating windows during which the irradiation
occurs, showed to eﬀectively and eﬃciently reduce the residual interplay eﬀect, especially
when using gating windows based on relative tumor motion amplitudes and allowing vari-
able initial breathing phases in diﬀerent fractions.
4D-MRI oﬀers several beneﬁcial possible applications for both oine (pre-treatment) and
online (real-time) MR-guided proton therapy of pancreatic cancer. The developed 4D-
MRI-based methods and analysis strategies can be utilized for motion quantiﬁcation,
pre-treatment estimations of the interplay eﬀect and determination of suitable treatment
strategies for pancreatic cancer patients.
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